A carregar...
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a devastating and fatal chronic lung disease. While current pharmacotherapies have improved patient quality of life, PAH drugs suffer from limitations in the form of short-term pharmacokinetics, instability, and poor organ specificity. Traditionally, nanotech...
Na minha lista:
| Publicado no: | Front Physiol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6055049/ https://ncbi.nlm.nih.gov/pubmed/30061840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2018.00890 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|